|

Asthma Clinical Trials in Michigan

12 recruiting studies across 7 cities

All Trials in Michigan

Phase
Trial Phase Location
A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice—Ann Arbor
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe AsthmaPhase 3Ann Arbor
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe AsthmaPhase 2Ann Arbor
Asthma and Technology in Emerging African American AdultsN/AAnn Arbor
Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued TreatmentPhase 3Ann Arbor
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With AsthmaPhase 3Detroit
Study to Evaluate the Safety, Pharmacology and Efficacy of WIN378 in Adults With Moderate or Severe AsthmaPhase 2Detroit
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled CorticosteroidsPhase 2Farmington Hills
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)Phase 3Flint
A Study to Learn About the Study Medicine Called Tilrekimig in People With Severe AsthmaPhase 3Flint
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)Phase 3Southfield
ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in AdultsPhase 2Southfield

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.